3 Dividend Stocks to Hold for the Next 10 Years
The article highlights three long-term dividend stocks. Merck (MRK) faces Keytruda patent expirations in the U.S. (2028) and Europe (2030), with 2025 revenue from Keytruda at about $32B, but it cites acquisitions (Verona Pharma, Terns Pharmaceuticals) and a pipeline of 50+ trials. Verizon (VZ) targets 750,000–1M net postpaid customers and notes fixed wireless (6M customers) and AI Connect. Equinix (EQIX) reports $2.44B revenue last quarter (+10% y/y) and is a REIT with a dividend raised for 11 s